The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
CAPITALSOURCE, INC. COM 14055X102 10,627 1,132,948 SH   DFND 1 0 1,132,948 0
GAP, INC. COM 364760108 178,222 4,270,830 SH   DFND 1 0 4,270,830 0
IRONWOOD PHARMACEUTICALS INC. COM Class A 4633X108 1,922 193,588 SH   DFND 1 0 193,588 0
VANGUARD INTL EQUITY INDEX F ALLWRLD EX US 922042775 15,533 351,260 SH   DFND   0 351,260 0
VANGUARD INTL EQUITY INDEX F FTSE EMR MKT ETF 922042858 17,897 461,312 SH   DFND   0 461,312 0